OptiNose's Grant - II Round

OptiNose raised a round of funding on November 09, 2012. Investors include Research Council of Norway.

OptiNose is a specialty pharmaceutical company built around a unique nasal delivery platform. The company is driven by an experienced, world-class team with expertise including drug and device develop…

Articles about OptiNose's Grant - II Round: